AtriCure completes acquisition of Estech AtriCure announced the completion of the previously announced acquisition of Endoscopic Technologies, known as Estech. AtriCure expects that the transaction will increase sales and marketing expense as well as research and development expenditures in order to accelerate clinical development and commercial sales of the combined product portfolio. While these expenses will increase on absolute dollar basis, AtriCure expects these expenses to decrease as a percentage of sales beginning in 2015. AtriCure expects the transaction to be dilutive to earnings in 2014 and accretive in 2015 and beyond.
News For ATRC From The Last 14 Days
Check below for free stories on ATRC the last two weeks.